Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Delirium Prevention in Mechanically Ventilated ICU Patients (DEMEL)
NCT03524937Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in delirium, sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2019; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03524937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03524937.